Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
---|
09/14/2000 | WO2000053749A2 Vascular adhesion molecules and modulation of their function |
09/14/2000 | WO2000053748A2 Casb618 polynucleotides and polypeptides and their use |
09/14/2000 | WO2000053747A1 Sialic acid-binding ig-like lectin (siglec) gene; ob-binding protein like (ob-bpl) |
09/14/2000 | WO2000053742A2 Polynucleotides and proteins encoded thereby |
09/14/2000 | WO2000053740A1 Method for screening biomolecule activity regulator |
09/14/2000 | WO2000053739A1 Fibers having nucleic acid immobilized thereon, alignment of fibers having nucleic acid immobilized thereon and slice thereof |
09/14/2000 | WO2000053738A2 Methods and compositions for regulating memory consolidation |
09/14/2000 | WO2000053737A2 Mitomycin biosynthetic gene cluster |
09/14/2000 | WO2000053733A2 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof |
09/14/2000 | WO2000053635A1 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions |
09/14/2000 | WO2000053631A1 Mammalian cytokines; related reagents and methods |
09/14/2000 | WO2000053628A2 Genes encoding human potassium channel proteins |
09/14/2000 | WO2000053623A1 Bifunctional molecules for delivery of therapeutics |
09/14/2000 | WO2000053616A2 Nucleotides and polynucleotides immobilised on a solid support via a disulphide linkage |
09/14/2000 | WO2000053232A1 Matriptase, a serine protease and its applications |
09/14/2000 | WO2000053218A1 Neurodegenerative disorder related gene |
09/14/2000 | WO2000053216A2 Use of casb616 polypeptides and polynucleotides for cancer treatment |
09/14/2000 | WO2000053012A1 Regulation of nucleic acid expression by heparan sulfate and biological equivalents thereof |
09/14/2000 | WO2000053005A1 HETEROGENOUS AND HOMOGENEOUS MOUSE VARIANTS LACKING sno GENE |
09/14/2000 | WO2000037685A3 Method of identifying a psychotropic agent using differential gene expression |
09/14/2000 | WO2000037675A3 Reporter gene assay for compounds which mimic or inhibit the physiological effect of the ob-protein |
09/14/2000 | WO2000037651A3 Method of screening for agrochemicals |
09/14/2000 | WO2000037504A3 Human monoclonal antibodies to ctla-4 |
09/14/2000 | WO2000035430A3 Homer a new target of treating psychiatric disorders |
09/14/2000 | WO2000031263A3 Gtpase associated proteins |
09/14/2000 | WO2000030425A3 Method of using pon-1 to decrease atheroma formation |
09/14/2000 | WO2000026408A3 A system for cell-based screening |
09/14/2000 | WO2000024913A3 Mn gene and protein |
09/14/2000 | WO2000023603A3 Methods of treatment of type 2 diabetes |
09/14/2000 | WO2000023599A3 Human proteins involved in endoplasmic reticulum protein degradation |
09/14/2000 | WO2000023588B1 G-protein coupled receptors |
09/14/2000 | WO2000022168A9 Carcinogen assay |
09/14/2000 | WO2000022166A3 Genes for assessing cardiovascular status and compositions for use thereof |
09/14/2000 | WO2000022129A9 Non-endogenous, constitutively activated human g protein-coupled receptors |
09/14/2000 | WO2000022125A9 6-protein-coupled receptor-like proteins, polynucleotides encoded by them, and methods of using same |
09/14/2000 | WO2000021975A9 Multiple fusion probes |
09/14/2000 | WO2000020852A9 Conductive organic sensors, arrays and methods of use |
09/14/2000 | WO2000020637A9 Method for identifying compounds affecting rna/rna binding protein interactions |
09/14/2000 | WO2000013018A3 Support for a method for determining analytes and a method for producing the support |
09/14/2000 | WO1999066875A3 Combined preparation of anti-infectiously active compounds which inhibit the 2-c-methylerythrose-4 metabolic pathway, and inhibitors of lipid metabolism |
09/14/2000 | WO1999064624A3 Method of generating nucleic acid hybrids for mutation analysis |
09/14/2000 | WO1999062941A9 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
09/14/2000 | CA2582809A1 Replica amplification of nucleic acid arrays |
09/14/2000 | CA2478736A1 Compositions and methods for the treatment of tumors |
09/14/2000 | CA2478730A1 Compositions and methods for the treatment of tumors |
09/14/2000 | CA2478728A1 Compositions and methods for the treatment of tumors |
09/14/2000 | CA2411514A1 Nucleotide compounds having a cleavable linker |
09/14/2000 | CA2372162A1 Method of labeling a nucleic acid amplicon with simultaneous contamination prevention |
09/14/2000 | CA2367334A1 Compositions and methods for the treatment of tumors |
09/14/2000 | CA2367313A1 Method for screening biomolecule activity regulator |
09/14/2000 | CA2367067A1 Heterogenous and homogeneous mouse variants lacking sno gene |
09/14/2000 | CA2366942A1 Genetic screening |
09/14/2000 | CA2366706A1 Mammalian cytokines; related reagents and methods |
09/14/2000 | CA2366689A1 Bifunctional molecules for delivery of therapeutics |
09/14/2000 | CA2366429A1 Methods and compositions for regulating memory consolidation |
09/14/2000 | CA2366147A1 Casb618 polynucleotides and polypeptides and their use |
09/14/2000 | CA2366124A1 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof |
09/14/2000 | CA2366112A1 A method for direct nucleic acid sequencing |
09/14/2000 | CA2366108A1 Nucleotide fragment, probe, primer, reagent and method for detecting a nucleotide sequence derived from pbr322 replication origin |
09/14/2000 | CA2366101A1 Intact cell assay for protein tyrosine phosphatases |
09/14/2000 | CA2366087A1 Sialic acid-binding ig-like lectin (siglec) gene; ob-binding protein like (ob-bpl) |
09/14/2000 | CA2365968A1 Novel plant genes and uses thereof |
09/14/2000 | CA2365904A1 Mitomycin biosynthetic gene cluster |
09/14/2000 | CA2365230A1 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions |
09/14/2000 | CA2365226A1 Immobilising polynucleotides |
09/14/2000 | CA2364877A1 Gene chip technology for determining memory genes |
09/14/2000 | CA2364275A1 Trait-associated gene identification method |
09/14/2000 | CA2362885A1 Human kallikrein-like genes |
09/14/2000 | CA2362670A1 Matriptase, a serine protease and its applications |
09/14/2000 | CA2362445A1 Fibers having nucleic acid immobilized thereon, alignment of fibers having nucleic acid immobilized thereon and slice thereof |
09/14/2000 | CA2362427A1 Compositions and methods for the treatment of immune related diseases |
09/14/2000 | CA2362422A1 Polynucleotides and proteins encoded thereby |
09/14/2000 | CA2362370A1 Use of casb616 polypeptides and polynucleotides for cancer treatment |
09/14/2000 | CA2361849A1 Promotion or inhibition of angiogenesis and cardiovascularization |
09/14/2000 | CA2361772A1 Method to detect male antifertility problems |
09/14/2000 | CA2331412A1 Method of identifying gene transcription patterns |
09/13/2000 | EP1035220A2 Oligonucleotide primers for efficient multiplex detection of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) and methods of use thereof |
09/13/2000 | EP1035219A1 Gastric helicobacter 16 S rDNA sequences from cattle and pigs and their use for detection and typing of Helicobacter strains |
09/13/2000 | EP1035218A1 Immobilization of molecules on surfaces via polymer brushes |
09/13/2000 | EP1035217A2 Method for prediction of PTH reactivity by polymorphism of PTHR gene |
09/13/2000 | EP1035216A1 Method of and apparatus for the detection of analytes |
09/13/2000 | EP1035215A2 Method and probe set for detecting cancer |
09/13/2000 | EP1035213A1 Method for enzyme assay |
09/13/2000 | EP1034785A2 Hepatitis C virus diagnostics and vaccines |
09/13/2000 | EP1034309A2 Method for producing complex dna methylation fingerprints |
09/13/2000 | EP1034308A1 Method of generating conditionally expressed mutant cells using expressible antisense sequences |
09/13/2000 | EP1034307A1 Methods for the detection of chromosomal aberrations |
09/13/2000 | EP1034306A1 Improved cycle sequencing thermal profiles |
09/13/2000 | EP1034305A1 Integrated circuit biochip microsystem |
09/13/2000 | EP1034304A1 Method for measuring the apoptosis |
09/13/2000 | EP1034303A1 Methods of detecting polynucleotide analytes |
09/13/2000 | EP1034302A1 $i(DE NOVO) OR "UNIVERSAL" SEQUENCING ARRAY |
09/13/2000 | EP1034301A1 Inhibition of an fgf-binding protein using ribozymes |
09/13/2000 | EP1034299A1 Method for suppressing multiple drug resistance in cancer cells |
09/13/2000 | EP1034284A1 Method and compositions useful for the activation of silent transgenes |
09/13/2000 | EP1034280A2 Cellulase produced by actinomycetes and method of producing same |
09/13/2000 | EP1034276A1 Novel era |
09/13/2000 | EP1034270A1 Compositions and methods of use of het |
09/13/2000 | EP1034268A1 G-protein coupled receptors and uses therefor |
09/13/2000 | EP1034267A1 Compositions and methods for inducing gene expression |